Pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Titan Biotech has informed that a meeting of the Board of Directors of the company will be held on Saturday, 4th February, 2023, consider and approve: The Unaudited Financial Results of the Company for the Third Quarter ended on 31st December, 2022 and Any other business matter with the permission of the Chair. The ‘Trading Window’ for dealing in securities of the Company as per SEBI (Prohibition of Insider Trading) Regulations 2015 and Code of Conduct for Prevention of Insider Trading of the Company by designated persons has already been closed from 31st December, 2022 will remain closed till 48 hours after declaration of aforesaid Financial Results of the Company and the same has been informed to the designated persons.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| BASF India | 4035.90 |
| Tata Chemicals | 782.10 |
| SRF | 2780.75 |
| Pidilite Inds. | 1476.15 |
| Deepak Nitrite | 1875.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: